iPro Professional CGM
Discover clinical insights not possible with A1C and fingersticks alone. Make important therapy adjustments with the iPro™ Continuous Glucose Monitor.
How It Works
iPro Continuous Glucose Monitor (CGM) provides a 3-day CGM evaluation of your patients’ glucose levels.
A tiny glucose sensor inserts under the user’s skin and records glucose levels every 5 minutes for 3 days. You can use the data to adjust therapy based on glucose level trends and patterns.
iPro CGM Advantages
- Continuous glucose monitoring reveals insights not apparent with fingerstick and A1C testing alone
- Medtronic Diabetes CGM technology is validated in more than 200 clinical publications
- Established CPT codes (95250 and 95251) for CGM services provided by clinics
- Quality service and support eases the way for you and your patients
Getting Started
Office Visit #1 – Patient Begins Evaluation
- Insert Glucose Sensor
- Synchronize iPro Recorder with a blood glucose (BG) meter
- Connect iPro Recorder to glucose sensor
- Provide patient with log sheet and instructions
Patient at Home
- Patient takes 4 fingersticks each day
- Patient uses a log sheet to record daily activities (eg, meals, exercise, insulin)
- System is waterproof and discreet
Office Visit #2 – Patient Evaluation Complete
- Remove glucose sensor and iPro Recorder
- Download iPro Recorder and BG meter data
- Note: nonsupported meters may require manual entry
- Generate reports and interpret results
View the clinical benefits of continuous glucose monitoring.
Indications for Use
The iPro System is intended to continuously record interstitial glucose levels in persons with diabetes mellitus. This information is intended to supplement, not replace, blood glucose information obtained using standard home glucose-monitoring devices.
The information collected by the iPro System may be downloaded and displayed on a computer and reviewed by healthcare professionals. This information may allow identification of patterns of glucose-level excursions above or below the desired range, facilitating therapy adjustments that may minimize these excursions. The iPro System:
- Is intended for prescription-use only
- Will not allow readings to be made available directly to patients in real time
- Provides readings that will be available for review by physicians only after the entire recording interval (72 hours)
- Is currently intended for occasional rather than everyday use
- Is to be used only as a supplement to, and not a replacement for, standard invasive measurement
- Is not intended to change patient management based on the numbers generated, but to guide future management of the patient based on response to trends noticed. That is, these trends or patterns may be used to suggest when to take fingerstick glucose measurements to better manage the patient.
The monitor, sensor, cable and test plug are intended for use with the Medtronic Diabetes iPro System.
The Sen-serter® is indicated only for insertion of the Medtronic Diabetes glucose sensor.
Contraindications
Successful operation of the iPro System requires adequate vision and hearing. Use of the iPro System is not recommended for patients whose impaired vision or hearing does not allow full recognition of the monitor signals and alarms, or who do not have a caregiver who can perform this function for them.
For complete safety information, including contraindications, warnings/complications, and potential complications, see product label or visit the Indications, Safety, and Warnings page.